Cargando…

Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016

PURPOSE: To describe sociodemographic, epidemiologic, and clinical characteristics of patients who were diagnosed with breast cancer and registered in the Institutional Tumor Registry of Argentina (RITA) as of April 2016. METHODS: This was an observational, descriptive case study in patients who wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Abriata, María Graciela, Macías, Guillermo Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426481/
https://www.ncbi.nlm.nih.gov/pubmed/30657735
http://dx.doi.org/10.1200/JGO.2016.009050
_version_ 1783405011234979840
author Abriata, María Graciela
Macías, Guillermo Raúl
author_facet Abriata, María Graciela
Macías, Guillermo Raúl
author_sort Abriata, María Graciela
collection PubMed
description PURPOSE: To describe sociodemographic, epidemiologic, and clinical characteristics of patients who were diagnosed with breast cancer and registered in the Institutional Tumor Registry of Argentina (RITA) as of April 2016. METHODS: This was an observational, descriptive case study in patients who were diagnosed with breast cancer between April 2012 and April 2016 and registered in RITA. Quantitative and qualitative analyses were done, including delay from symptoms to first consultation, delay from diagnosis to treatment (opportunities), as well as patients’ survival (Kaplan-Meier and log-rank tests). RESULTS: There were 4,883 identified patients and 4,950 tumors. The mean age of patients was 57.6 years (median, 56 years); 60% of patients had completed elementary studies, 46.8% had some health coverage, and 85.4% of diagnoses were made by tumor histology (TNM stage: T2 19%, N0 20%, M0 29.1%; clinical stages II and III: 34.7%). In terms of morphology, 89.6% of primary tumors had malignant behavior (76% ductal, 8% lobular); and for immunohistochemistry, 34.3% were estrogen receptor positive/progesterone receptor positive/human epidermal growth factor receptor 2 negative. The longest delays analyzed were from diagnosis date to the beginning of first treatment. Survival rates were 96% for up to 24 months and 84.7% for up to 36 months. CONCLUSION: For the first time in Argentina, there is systematized information on the care of oncology patients at public health institutions, which is useful for improving patients’ care. We found that RITA collects important information for the identification of groups with similar sociodemographic and clinical characteristics that could show different vulnerabilities along the disease process.
format Online
Article
Text
id pubmed-6426481
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-64264812019-04-09 Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016 Abriata, María Graciela Macías, Guillermo Raúl J Glob Oncol Special Articles PURPOSE: To describe sociodemographic, epidemiologic, and clinical characteristics of patients who were diagnosed with breast cancer and registered in the Institutional Tumor Registry of Argentina (RITA) as of April 2016. METHODS: This was an observational, descriptive case study in patients who were diagnosed with breast cancer between April 2012 and April 2016 and registered in RITA. Quantitative and qualitative analyses were done, including delay from symptoms to first consultation, delay from diagnosis to treatment (opportunities), as well as patients’ survival (Kaplan-Meier and log-rank tests). RESULTS: There were 4,883 identified patients and 4,950 tumors. The mean age of patients was 57.6 years (median, 56 years); 60% of patients had completed elementary studies, 46.8% had some health coverage, and 85.4% of diagnoses were made by tumor histology (TNM stage: T2 19%, N0 20%, M0 29.1%; clinical stages II and III: 34.7%). In terms of morphology, 89.6% of primary tumors had malignant behavior (76% ductal, 8% lobular); and for immunohistochemistry, 34.3% were estrogen receptor positive/progesterone receptor positive/human epidermal growth factor receptor 2 negative. The longest delays analyzed were from diagnosis date to the beginning of first treatment. Survival rates were 96% for up to 24 months and 84.7% for up to 36 months. CONCLUSION: For the first time in Argentina, there is systematized information on the care of oncology patients at public health institutions, which is useful for improving patients’ care. We found that RITA collects important information for the identification of groups with similar sociodemographic and clinical characteristics that could show different vulnerabilities along the disease process. American Society of Clinical Oncology 2019-01-18 /pmc/articles/PMC6426481/ /pubmed/30657735 http://dx.doi.org/10.1200/JGO.2016.009050 Text en © 2019 by American Society of Clinical Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Special Articles
Abriata, María Graciela
Macías, Guillermo Raúl
Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title_full Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title_fullStr Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title_full_unstemmed Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title_short Patients With Breast Cancer: Report From a National Hospital–Based Cancer Registry in Argentina, 2012 to 2016
title_sort patients with breast cancer: report from a national hospital–based cancer registry in argentina, 2012 to 2016
topic Special Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426481/
https://www.ncbi.nlm.nih.gov/pubmed/30657735
http://dx.doi.org/10.1200/JGO.2016.009050
work_keys_str_mv AT abriatamariagraciela patientswithbreastcancerreportfromanationalhospitalbasedcancerregistryinargentina2012to2016
AT maciasguillermoraul patientswithbreastcancerreportfromanationalhospitalbasedcancerregistryinargentina2012to2016